Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: Possible role of insulin-like growth factors and insulin-like growth factor-binding proteins

Surgery

Volumn 127, Issue 1, 2000, Pages 99-103

  Torre, Giancarlo ^a   Barreca, Antonina ^a   Borgonovo, Giacomo ^a   Minuto, Michele ^a   Ansaldo, Gian Luca ^a   Varaldo, Emanuela ^a   Minuto, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR; THYROTROPIN;

ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; GOITER; HORMONAL REGULATION; HUMAN; IMMUNOBLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECURRENT DISEASE; THYROIDECTOMY;

EID: 0033979814     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.100937     Document Type: Article

References (24)

1. 1. Gaitan E, Nelson NC, Poole GV. Endemic goiter and endemic thyroid disorders. World J Surg 1991;15:205-15.
2. 2. Kraimps JL, Marechaud R, Gineste D, Fieuzal S, Metaye T, Carretier M, et al. Analysis and prevention of recurrent goiter. Surg Gynecol Obstet 1993;176:319-22.
3. 3. LaGamma A, Letoquart JP, Kumin N, Chaperon J, Mambrini A. Goitre nodulaire: analyse retrospective sur 608 cas. J Chir (Paris) 1993;130:391-6.
4. 4. Sugenoya A, Masuda M, Komatsu M, Yokoyama S, Shimizu T, Fujimori M, et al. Adenomatous goiter: therapeutic strategy, postoperative, outcome, and study of epidermal growth factor receptor. Br J Surg 1992;79:404-6.
5. 5. Roger P, Taton M, Van Sandle J, Du Mont JE. Mitogenic: effects of thyrotropin and adenosine 3′5′-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 1988;66:1158-63.
6. 6. Ibis E, Erbay G, Aras G, Akin A. Postoperative goiter recurrence rate in Turkey. Acta Endocrinol 1991;125:33-7.
7. 7. Miccoli P, Antonelli A, Iacconi P, Alberti B, Gambuzza C, Baschieri L. Prospective, randomized, double blind study, about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at a third year of follow-up. Surgery 1993;114:1097-102.
8. 8. Rinderknecht E, Humbel RE. The amino acid sequence of insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978;253:2769-76.
9. 9. Binoux M, Hardouin S, Lassarre C, Hossenlopp P. Evidence for production by the liver of two IGF binding proteins with similar molecular weights but different affinities for IGF-I and IGF-II: their relations with serum and cerebrospinal fluid IGF binding proteins. J Clin Endocrinol Metab 1982;55:600-2.
10. 10. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentraion of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 1984;81:935-9.
11. 11. D'Eercole AJ, Applewhite GT, Underwood LE. Evidence that somatomedi is synthesized by multiple tissues in the fetus. Dev Biol 1980;75:315-28.
12. 12. Beaton GR, Singh V. Age-dependent variation in cartilage response to somatomedin [abstract]. Pediatr Res 1975;9:683.
13. 13. Moses AC, Nissley SP, Short PA, Rechler MM, Podskanly JM. Purification and characterization of multiplication stimulating activity. Eur J Biochem 1980;103:387-400.
14. 14. Rabinovitch A, Quigley C, Russel T, Patel Y, Mintz DH. Insulin and multiplication-stimulating activity (insulin-like growth factor) stimulates islet beta-cells replication in neonatal rat pancreatic monolayer cultures. Diabetes 1982;31:160-4.
15. 15. Schimpff RM, Repellin AM, Salvatori A, Thieriot-Prevost G, Chatelain P. Effect of purified somatomedins on thymidine incorporation into lectin-activated human lymphocytes. Acta Endocrinol 1983;102:21-6.
16. 16. Reddan JR, Wilason-Dziedizic D. Insulin-like growth factor and epidermal growth factor trigger mitosis in lenses cultured in a serum-free medium. Invest Ophth Vis Sci 1983;24:409-16.
17. 17. Lenoir D, Honegger P. Insulin-like factor I (IGF-I) stimulates DNA synthesis in fetal rat brain cell cultures. Brain Res 1983;283:205-13.
18. 18. Zapf J, Schoenle E, Jagars G, Sand I, Grunwald J, Froesch ER. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Ivest 1979;63:1077-84.
19. 19. Cohen KL, Nissley SP. The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta Endocrinol 1976;83:243-58.
20. 20. Massague J, Czeck MP. The subunit structures of two distinct receptors for insulin-like growth factors 1 and 2 and their relationship to the insulin receptor. J Biol Chem 1982;257:5038-46.
21. 21. Tramontano D, Cushing GW, Moses AC, Ingbar SH. Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology 1986;119:940-2.
22. 22. Tramontano D, Moses AC, Veneziani BM, Ingbar SH. Adenosine 3′5′-monophosphate mediates the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL-5 cells. Endocrinology 1988;122:127-35.
23. 23. Tosta Z, Chabaud O, Cheboath J. Identification of thyroglobulin mRNA sequences in the nucleus and cytoplasm of cultured thyroid cells: a fast transcriptional effect of thyrotropin. Biochem Biophys Res Commun 1983;116:54-60.
24. 24. Minuto F, Barreca A, Del Monte P, Cariola G, Torre G, Giordano G. Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I binding protein content in human thyroid tissue. J Clin Endocrinol Metab 1989;68:621-6.